Berkman Charles S
Insider CIK 1392266 · OABI See Remarks · NONE CLO & Secretary, Director · LGND VP, Gen. Counsel & Secretary
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OABI OmniAb, Inc. | M Exercise deriv | 2026-04-07 | 2026-04-07 | 13,542 | — | $0 | 111,042 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2026-04-07 | 2026-04-07 | 7,157 | $1.49 | $10.7K | 399,085 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2026-04-07 | 2026-04-07 | 13,542 | — | $0 | 406,242 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2026-02-18 | 2026-02-18 | 60,000 | — | $0 | 124,584 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2026-02-18 | 2026-02-18 | 600,000 | — | $0 | 600,000 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2026-02-18 | 2026-02-18 | 18,750 | — | $0 | 64,584 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2026-02-18 | 2026-02-18 | 9,673 | $1.71 | $16.5K | 392,700 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2026-02-18 | 2026-02-18 | 18,750 | — | $0 | 402,373 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2026-02-17 | 2026-02-17 | 6,990 | $1.70 | $11.9K | 383,623 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2026-02-16 | 2026-02-17 | 13,542 | — | $0 | 83,334 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2026-02-16 | 2026-02-17 | 13,542 | — | $0 | 390,613 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2025-12-08 | 2025-12-09 | 8,044 | $1.96 | $15.8K | 377,071 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2025-12-07 | 2025-12-09 | 15,621 | — | $0 | 96,876 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2025-12-07 | 2025-12-09 | 15,621 | — | $0 | 385,115 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2025-04-07 | 2025-04-07 | 13,542 | — | $0 | 112,497 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2025-04-07 | 2025-04-07 | 13,542 | — | $0 | 370,418 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2025-04-07 | 2025-04-07 | 7,206 | $2.00 | $14.4K | 363,212 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2025-02-19 | 2025-02-19 | 7,255 | $3.67 | $26.6K | 356,876 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2025-02-18 | 2025-02-19 | 56,250 | — | $0 | 126,039 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2025-02-18 | 2025-02-19 | 337,500 | — | $0 | 337,500 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2025-02-18 | 2025-02-19 | 8,215 | $3.68 | $30.2K | 364,131 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2025-02-16 | 2025-02-19 | 13,541 | — | $0 | 69,789 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2025-02-16 | 2025-02-19 | 13,541 | — | $0 | 372,346 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2025-02-15 | 2025-02-19 | 15,615 | — | $0 | 83,330 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2025-02-15 | 2025-02-19 | 15,615 | — | $0 | 358,805 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2025-01-21 | 2025-01-22 | 25,489 | $3.24 | $82.6K | 343,190 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2025-01-17 | 2025-01-22 | 45,294 | — | $0 | 368,679 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2024-12-09 | 2024-12-10 | 8,022 | $4.13 | $33.1K | 323,385 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-12-07 | 2024-12-10 | 15,621 | — | $0 | 98,945 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-12-07 | 2024-12-10 | 15,621 | — | $0 | 331,407 | SEC↗ |
| OABI OmniAb, Inc. | S Sale | 2024-04-08 | 2024-04-09 | 6,954 | $5.27 | $36.6K | 292,617 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-04-07 | 2024-04-09 | 13,541 | — | $0 | 114,566 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-04-07 | 2024-04-09 | 13,541 | — | $0 | 299,571 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2024-02-16 | 2024-02-20 | 243,750 | — | $0 | 243,750 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2024-02-16 | 2024-02-20 | 40,625 | — | $0 | 128,107 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-02-15 | 2024-02-20 | 5,698 | — | $0 | 87,482 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-02-15 | 2024-02-20 | 15,624 | — | $0 | 93,180 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-02-15 | 2024-02-20 | 15,624 | — | $0 | 287,941 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2024-02-15 | 2024-02-20 | 5,575 | $5.54 | $30.9K | 282,366 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-02-15 | 2024-02-20 | 5,698 | — | $0 | 288,064 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2024-02-15 | 2024-02-20 | 2,034 | $5.54 | $11.3K | 286,030 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2024-01-02 | 2024-01-03 | 17,556 | — | $0 | 108,804 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2024-01-02 | 2024-01-03 | 7,195 | $6.25 | $45.0K | 272,317 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2024-01-02 | 2024-01-03 | 17,556 | — | $0 | 279,512 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2023-12-07 | 2023-12-11 | 15,622 | — | $0 | 126,360 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise deriv | 2023-12-07 | 2023-12-12 | 15,622 | — | $0 | 126,360 | SEC↗ |
| OABI OmniAb, Inc. | M Exercise | 2023-12-07 | 2023-12-11 | 15,622 | — | $0 | 267,359 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2023-12-07 | 2023-12-11 | 5,403 | $4.85 | $26.2K | 261,956 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2023-04-07 | 2023-04-11 | 243,750 | — | $0 | 243,750 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2023-04-07 | 2023-04-11 | 40,625 | — | $0 | 414,564 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2023-02-15 | 2023-02-17 | 5,404 | $3.80 | $20.5K | 376,105 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2023-02-15 | 2023-02-17 | 1,973 | $3.80 | $7.5K | 381,509 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2023-02-15 | 2023-02-17 | 2,166 | $3.80 | $8.2K | 373,939 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2023-01-03 | 2023-01-05 | 46,864 | — | $0 | 383,482 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2022-12-28 | 2022-12-30 | 6,518 | $3.66 | $23.9K | 336,618 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-12-07 | 2022-12-09 | 175,477 | — | $0 | 175,477 | SEC↗ |
| OABI OmniAb, Inc. | F Tax w/h | 2022-12-01 | 2022-12-05 | 10,580 | $3.35 | $35.4K | 343,136 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2022-11-01 | 2024-04-23 | 366,511 | — | $0 | 305,412 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | D To issuer deriv | 2022-11-01 | 2022-11-03 | 20,126 | — | $0 | 0 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer deriv | 2022-11-01 | 2022-11-03 | 12,797 | — | $0 | 0 | SEC↗ |
| NONE OmniAb Operations, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 35,810 | — | $0 | 35,810 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer deriv | 2022-11-01 | 2022-11-03 | 35,810 | — | $0 | 0 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer deriv | 2022-11-01 | 2022-11-03 | 1,701 | — | $0 | 0 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer deriv | 2022-11-01 | 2022-11-03 | 3,627 | — | $0 | 0 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer deriv | 2022-11-01 | 2022-11-03 | 5,966 | — | $0 | 0 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer deriv | 2022-11-01 | 2022-11-03 | 8,117 | — | $0 | 0 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer deriv | 2022-11-01 | 2022-11-03 | 15,043 | — | $0 | 0 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer deriv | 2022-11-01 | 2022-11-03 | 6,076 | — | $0 | 0 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 29,772 | — | $0 | 29,772 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 8,339 | — | $0 | 8,339 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 175,477 | — | $0 | 175,477 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 17,778 | — | $0 | 17,778 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 73,716 | — | $0 | 73,716 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 29,237 | — | $0 | 29,237 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 39,777 | — | $0 | 39,777 | SEC↗ |
| OABI OmniAb, Inc. | A Award deriv | 2022-11-01 | 2022-11-03 | 62,710 | — | $0 | 62,710 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | D To issuer | 2022-11-01 | 2022-11-03 | 11,944 | — | $0 | 23,825 | SEC↗ |
| NONE OmniAb Operations, Inc. | A Award | 2022-11-01 | 2022-11-03 | 15,409 | — | $0 | 52,587 | SEC↗ |
| NONE OmniAb Operations, Inc. | D To issuer | 2022-11-01 | 2022-11-03 | 52,587 | — | $0 | 0 | SEC↗ |
| OABI OmniAb, Inc. | A Award | 2022-11-01 | 2022-11-03 | 353,716 | — | $0 | 353,716 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-06-10 | 2022-06-14 | 5,375 | — | $0 | 35,769 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-05-05 | 2022-05-09 | 20,126 | — | $0 | 20,126 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-02-15 | 2022-02-16 | 633 | $123.68 | $78.3K | 30,971 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-02-15 | 2022-02-16 | 577 | $123.68 | $71.4K | 30,394 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-02-15 | 2022-02-16 | 368 | $123.68 | $45.5K | 31,604 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-01-26 | 2022-01-28 | 2,401 | — | $0 | 30,292 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-01-26 | 2022-01-28 | 830 | $113.68 | $94.4K | 33,298 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-01-26 | 2022-01-28 | 3,836 | — | $0 | 34,128 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2022-01-26 | 2022-01-28 | 1,326 | $113.68 | $150.7K | 31,972 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-02-15 | 2021-02-18 | 442 | $172.46 | $76.2K | 27,891 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-02-15 | 2021-02-18 | 368 | $172.46 | $63.5K | 28,333 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-02-15 | 2021-02-18 | 205 | $172.46 | $35.4K | 28,701 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2021-02-04 | 2021-02-05 | 18,097 | $178.50 | $3.23M | 28,906 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2021-02-03 | 2021-02-05 | 6,955 | — | $0 | 6,955 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-02-03 | 2021-02-05 | 3,491 | — | $0 | 47,003 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-01-25 | 2021-01-27 | 1,335 | — | $0 | 42,450 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-01-25 | 2021-01-27 | 509 | $156.10 | $79.5K | 41,941 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-01-25 | 2021-01-27 | 2,401 | — | $0 | 44,342 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2021-01-25 | 2021-01-27 | 830 | $156.01 | $129.5K | 43,512 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2020-06-30 | 2020-07-01 | 238 | $89.03 | $21.2K | 41,115 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2020-06-04 | 2020-06-05 | 11,146 | $118.59 | $1.32M | 40,877 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2020-02-15 | 2020-02-18 | 367 | $97.23 | $35.7K | 52,023 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2020-02-15 | 2020-02-18 | 207 | $97.23 | $20.1K | 52,390 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2020-02-15 | 2020-02-18 | 307 | $97.23 | $29.8K | 52,597 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2020-02-13 | 2020-02-18 | 17,220 | — | $0 | 17,220 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2020-02-13 | 2020-02-18 | 3,835 | — | $0 | 52,904 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-12-20 | 2019-12-26 | 1,335 | — | $0 | 49,615 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-12-20 | 2019-12-26 | 1,693 | — | $0 | 48,865 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-12-20 | 2019-12-26 | 585 | $105.87 | $61.9K | 48,280 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2019-12-20 | 2019-12-26 | 546 | $105.87 | $57.8K | 49,069 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2019-08-05 | 2019-08-06 | 669 | — | $0 | 1,948 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2019-08-05 | 2019-08-06 | 424 | — | $0 | 4,153 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2019-08-05 | 2019-08-06 | 424 | $85.79 | $36.4K | 47,172 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2019-08-05 | 2019-08-06 | 669 | $56.26 | $37.6K | 46,748 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2019-06-28 | 2019-07-02 | 182 | $97.03 | $17.7K | 46,079 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2019-02-11 | 2019-02-13 | 14,649 | — | $0 | 14,649 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-02-11 | 2019-02-13 | 3,202 | — | $0 | 45,897 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-01-23 | 2019-01-25 | 1,412 | — | $0 | 42,695 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-01-23 | 2019-01-25 | 1,370 | — | $0 | 41,283 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2019-01-10 | 2019-01-14 | 244 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2019-01-10 | 2019-01-14 | 1,931 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2019-01-10 | 2019-01-14 | 675 | — | $0 | 2,617 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2019-01-10 | 2019-01-14 | 1,931 | $74.42 | $143.7K | 39,238 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2019-01-10 | 2019-01-14 | 675 | $56.26 | $38.0K | 39,913 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2019-01-10 | 2019-01-14 | 244 | $21.92 | $5.3K | 37,307 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-12-17 | 2018-12-17 | 3,400 | — | $0 | 244 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-12-17 | 2018-12-17 | 3,400 | $21.92 | $74.5K | 37,063 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-10-24 | 2018-10-25 | 1,212 | — | $0 | 3,644 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-10-24 | 2018-10-25 | 2,688 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-10-24 | 2018-10-25 | 2,688 | $14.47 | $38.9K | 32,451 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-10-24 | 2018-10-25 | 1,212 | $21.92 | $26.6K | 33,663 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-10-11 | 2018-10-12 | 2,000 | — | $0 | 2,688 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-10-11 | 2018-10-12 | 2,000 | $14.47 | $28.9K | 29,763 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-09-17 | 2018-09-18 | 2,813 | — | $0 | 6,830 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-09-17 | 2018-09-18 | 2,813 | $250.69 | $705.2K | 27,763 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-09-17 | 2018-09-18 | 2,813 | $100.38 | $282.4K | 30,576 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-09-04 | 2018-09-05 | 5,985 | — | $0 | 1,931 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-09-04 | 2018-09-05 | 7,077 | — | $0 | 3,292 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-09-04 | 2018-09-05 | 5,886 | — | $0 | 4,577 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-09-04 | 2018-09-05 | 469 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-09-04 | 2018-09-05 | 5,886 | $85.79 | $505.0K | 47,180 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-09-04 | 2018-09-05 | 7,077 | $56.26 | $398.2K | 41,294 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-09-04 | 2018-09-05 | 5,985 | $74.42 | $445.4K | 34,217 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-09-04 | 2018-09-05 | 19,417 | $254.99 | $4.95M | 27,763 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-09-04 | 2018-09-05 | 469 | $21.92 | $10.3K | 28,232 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2018-06-29 | 2018-07-03 | 180 | $117.84 | $21.2K | 27,763 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2018-03-06 | 2018-03-06 | 392 | $165.87 | $65.0K | 27,583 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2018-03-06 | 2018-03-06 | 1,136 | — | $0 | 27,975 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2018-03-02 | 2018-03-06 | 9,292 | — | $0 | 9,292 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2018-03-02 | 2018-03-06 | 1,780 | — | $0 | 26,839 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2018-02-15 | 2018-02-16 | 252 | $157.18 | $39.6K | 25,319 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2018-02-15 | 2018-02-16 | 524 | $157.18 | $82.4K | 25,571 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2018-02-15 | 2018-02-16 | 260 | $157.18 | $40.9K | 25,059 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-12-28 | 2017-12-29 | 2,847 | — | $0 | 27,270 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | F Tax w/h | 2017-12-28 | 2017-12-29 | 1,175 | $138.66 | $162.9K | 26,095 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-08-09 | 2017-08-10 | 18,625 | $126.96 | $2.36M | 24,423 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2017-06-30 | 2017-07-05 | 243 | $87.13 | $21.2K | 43,048 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2017-02-24 | 2017-02-28 | 9,643 | — | $0 | 9,643 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-02-24 | 2017-02-28 | 2,259 | — | $0 | 42,805 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-02-24 | 2017-02-28 | 2,619 | — | $0 | 40,546 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2016-08-05 | 2016-08-09 | 5,688 | — | $0 | 10,369 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2016-08-05 | 2016-08-09 | 4,947 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2016-08-05 | 2016-08-09 | 3,333 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2016-08-05 | 2016-08-09 | 4,295 | — | $0 | 469 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2016-08-05 | 2016-08-09 | 12,084 | — | $0 | 7,916 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-08-05 | 2016-08-09 | 4,295 | $123.16 | $529.0K | 29,647 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2016-08-05 | 2016-08-09 | 4,295 | $21.92 | $94.1K | 33,942 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-08-05 | 2016-08-09 | 5,688 | $123.16 | $700.5K | 29,647 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2016-08-05 | 2016-08-09 | 3,333 | $40.86 | $136.2K | 37,927 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2016-08-05 | 2016-08-09 | 4,947 | $42.90 | $212.2K | 34,594 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-08-05 | 2016-08-09 | 12,084 | $123.16 | $1.49M | 29,647 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2016-08-05 | 2016-08-09 | 5,688 | $56.26 | $320.0K | 35,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2016-08-05 | 2016-08-09 | 12,084 | $74.42 | $899.3K | 41,731 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2016-02-11 | 2016-02-16 | 10,463 | — | $0 | 10,463 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2016-02-11 | 2016-02-16 | 2,193 | — | $0 | 29,647 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2015-07-13 | 2015-07-14 | 1,000 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2015-07-13 | 2015-07-14 | 1,000 | $53.10 | $53.1K | 27,454 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2015-07-10 | 2015-07-14 | 5,625 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2015-07-10 | 2015-07-14 | 8,442 | — | $0 | 4,688 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2015-07-10 | 2015-07-14 | 5,625 | $10.05 | $56.5K | 32,079 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2015-07-10 | 2015-07-14 | 8,442 | $14.47 | $122.2K | 40,521 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-07-10 | 2015-07-14 | 2,404 | $98.15 | $236.0K | 38,117 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-07-10 | 2015-07-14 | 8,838 | $99.18 | $876.6K | 29,279 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-07-10 | 2015-07-14 | 2,825 | $99.86 | $282.1K | 26,454 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2015-06-30 | 2015-07-01 | 465 | $45.67 | $21.2K | 26,454 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2015-03-16 | 2015-03-18 | 4,130 | — | $0 | 4,764 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2015-03-16 | 2015-03-18 | 1,134 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-03-16 | 2015-03-18 | 6,000 | $74.51 | $447.1K | 25,989 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2015-03-16 | 2015-03-18 | 1,134 | $14.47 | $16.4K | 27,123 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2015-03-16 | 2015-03-18 | 4,130 | $21.92 | $90.5K | 30,119 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-03-16 | 2015-03-18 | 4,130 | $74.58 | $308.0K | 25,989 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-03-16 | 2015-03-18 | 1,134 | $74.58 | $84.6K | 25,989 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2015-02-10 | 2015-02-11 | 16,057 | $56.26 | $903.4K | 16,057 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2015-02-10 | 2015-02-11 | 4,556 | — | $0 | 31,989 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2014-12-31 | 2015-01-05 | 126 | $45.23 | $5.7K | 27,433 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2014-12-31 | 2015-03-18 | 126 | $45.23 | $5.7K | 27,433 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2014-06-30 | 2014-07-01 | 329 | $43.79 | $14.4K | 27,307 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-05-27 | 2014-05-28 | 486 | — | $0 | 1,134 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-05-27 | 2014-05-28 | 347 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-05-27 | 2014-05-28 | 1,666 | — | $0 | 8,894 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-05-27 | 2014-05-28 | 347 | $9.96 | $3.5K | 27,325 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-05-27 | 2014-05-28 | 4,667 | $66.89 | $312.2K | 26,978 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-05-27 | 2014-05-28 | 486 | $66.93 | $32.5K | 26,978 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-05-27 | 2014-05-28 | 347 | $66.93 | $23.2K | 26,978 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-05-27 | 2014-05-28 | 1,666 | $21.92 | $36.5K | 28,644 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-05-27 | 2014-05-28 | 486 | $14.47 | $7.0K | 27,464 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-05-27 | 2014-05-28 | 1,666 | $66.93 | $111.5K | 26,978 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-13 | 2014-02-14 | 2,000 | — | $0 | 13,130 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-13 | 2014-02-14 | 2,000 | $14.47 | $28.9K | 31,645 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 386 | — | $0 | 4,947 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 20,000 | $74.42 | $1.49M | 20,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 1,736 | — | $0 | 347 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 4,779 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 1,000 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 1,166 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 4,584 | — | $0 | 10,560 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 1,230 | — | $0 | 1,620 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 1,736 | $9.96 | $17.3K | 29,645 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 1,736 | $74.50 | $129.3K | 27,909 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 1,230 | $74.50 | $91.6K | 29,645 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 1,230 | $14.47 | $17.8K | 30,875 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 4,779 | $74.50 | $356.0K | 29,645 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 4,779 | $10.05 | $48.0K | 34,424 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 4,584 | $74.50 | $341.5K | 29,645 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 4,584 | $21.92 | $100.5K | 34,229 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 1,000 | $74.50 | $74.5K | 29,645 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 1,000 | $16.14 | $16.1K | 30,645 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 1,166 | $74.50 | $86.9K | 29,645 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 1,166 | $21.00 | $24.5K | 30,811 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 386 | $74.50 | $28.8K | 29,645 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 386 | $42.90 | $16.6K | 30,031 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2014-02-12 | 2014-02-14 | 2,500 | — | $0 | 29,645 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2013-12-31 | 2014-01-02 | 209 | $33.92 | $7.1K | 27,145 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2013-08-30 | 2013-09-04 | 9,499 | — | $0 | 3,834 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2013-08-30 | 2013-09-04 | 7,020 | — | $0 | 2,850 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2013-08-30 | 2013-09-04 | 11,804 | — | $0 | 4,862 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2013-08-30 | 2013-09-04 | 4,862 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2013-08-30 | 2013-09-04 | 3,834 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2013-08-30 | 2013-09-04 | 312 | — | $0 | 5,625 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2013-08-30 | 2013-09-04 | 4,862 | $16.14 | $78.5K | 26,624 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2013-08-30 | 2013-09-04 | 11,804 | $47.54 | $561.2K | 17,928 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2013-08-30 | 2013-09-04 | 9,499 | $47.54 | $451.6K | 17,928 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2013-08-30 | 2013-09-04 | 9,499 | $21.00 | $199.5K | 27,427 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2013-08-30 | 2013-09-04 | 312 | $10.05 | $3.1K | 26,936 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2013-08-30 | 2013-09-04 | 11,804 | $16.14 | $190.5K | 29,732 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2013-08-30 | 2013-09-04 | 3,834 | $21.00 | $80.5K | 21,762 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2013-08-30 | 2013-09-04 | 7,020 | $47.54 | $333.7K | 17,928 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2013-08-30 | 2013-09-04 | 7,020 | $14.47 | $101.6K | 24,948 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2013-08-19 | 2013-08-20 | 4,284 | — | $0 | 5,937 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2013-08-19 | 2013-08-20 | 4,284 | $10.05 | $43.1K | 17,928 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2013-08-16 | 2013-08-20 | 14,583 | — | $0 | 2,083 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2013-08-16 | 2013-08-20 | 14,583 | $42.63 | $621.7K | 13,644 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2013-08-16 | 2013-08-20 | 14,583 | $9.96 | $145.2K | 28,227 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2013-06-28 | 2013-07-01 | 815 | $17.36 | $14.1K | 13,644 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2013-05-10 | 2013-05-13 | 4,000 | $26.66 | $106.6K | 12,829 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2013-02-15 | 2013-02-19 | 15,144 | $21.92 | $332.0K | 15,144 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2013-02-15 | 2013-02-19 | 4,856 | $21.92 | $106.4K | 4,856 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2013-02-15 | 2013-02-19 | 2,500 | — | $0 | 16,829 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2012-09-07 | 2012-09-10 | 4,249 | $18.77 | $79.8K | 14,329 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2012-06-29 | 2012-07-03 | 1,250 | $10.12 | $12.6K | 18,578 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2012-03-08 | 2012-03-08 | 106 | $15.77 | $1.7K | 17,328 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2012-03-08 | 2012-03-08 | 3,500 | $15.76 | $55.2K | 17,434 | SEC↗ |
| LGNDD LIGAND PHARMACEUTICALS INC | A Award deriv | 2012-02-09 | 2012-02-13 | 9,870 | $14.47 | $142.8K | 9,870 | SEC↗ |
| LGNDD LIGAND PHARMACEUTICALS INC | A Award deriv | 2012-02-09 | 2012-02-13 | 15,130 | $14.47 | $218.9K | 15,130 | SEC↗ |
| LGNDD LIGAND PHARMACEUTICALS INC | A Award | 2012-02-09 | 2012-02-13 | 5,000 | — | $0 | 20,934 | SEC↗ |
| LGNDD LIGAND PHARMACEUTICALS INC | J Other | 2011-12-30 | 2012-01-06 | 1,238 | $10.09 | $12.5K | 15,934 | SEC↗ |